Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.6000 (0%) ($7.6000 - $7.6500) on Thu. May. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.93% (three month average) | RSI | 49 | Latest Price | $7.6000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.8% a day on average for past five trading days. | Weekly Trend | ANPC declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) PCY(10%) LIT(9%) FXI(8%) HYG(8%) | Factors Impacting ANPC price | ANPC will decline at least -2.465% in a week (0% probabilities). SHY(-16%) XBI(-7%) IBB(-6%) XLU(-5%) XLP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.465% (StdDev 4.93%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $7.76 | 5 Day Moving Average | $7.67(-0.91%) | 10 Day Moving Average | $7.76(-2.06%) | 20 Day Moving Average | $7.76(-2.06%) | To recent high | -22.8% | To recent low | 7.5% | Market Cap | $65m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |